Logo

Thomas Tuschl, Steven Samuelsson

Nov 15, 2007
Premium
Rockefeller University researcher Thomas Tuschl was recently awarded the Max Delbruck Medal by the Max Delbruck Center for Molecular Medicine in Berlin for his pioneering work in RNAi.
 
Among Tuschl’s discoveries was that RNAi existed in mammalian cells and could be triggered using short dsRNA.
 
 
Steven Samuelsson has taken the post of director of imaging in SRI International’s Biosciences Division.
 
In the role, Samuelsson will run the microscopy and imaging-based assay efforts for drug development and discovery.
 
He formerly was associate director of experimental pathology at Eyetech Pharmaceuticals.

Filed under

Gene Silencing/Gene Editing
RNAi
Breaking News
The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.